1
|
Cocci P, Mosconi G, Palermo FA. Effect of polycyclic aromatic hydrocarbons on homeobox gene expression during embryonic development of cuttlefish, Sepia officinalis. CHEMOSPHERE 2023; 325:138315. [PMID: 36889469 DOI: 10.1016/j.chemosphere.2023.138315] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/17/2022] [Revised: 02/24/2023] [Accepted: 03/03/2023] [Indexed: 06/18/2023]
Abstract
Polycyclic aromatic hydrocarbons (PAHs) are persistent organic pollutants (POPs) commonly found in marine environments. Their bioaccumulation can cause harm to aquatic organisms, including invertebrates, particularly during the early stages of embryonic development. In this study, we evaluated, for the first time, the patterns of PAH accumulation in both capsule and embryo of common cuttlefish (Sepia officinalis). In addition, we explored the effects of PAHs by analysing the expression profiles of seven homeobox genes [i.e., gastrulation brain homeobox (GBX), paralogy group labial/Hox1 (HOX1), paralogy group Hox3 (HOX3), dorsal root ganglia homeobox (DRGX), visual system homeobox (VSX), aristaless-like homeobox (ARX) and LIM-homeodomain transcription factor (LHX3/4)]. We found that PAH levels in egg capsules were higher than those observed in chorion membranes (35.1 ± 13.3 ng/g vs 16.4 ± 5.9 ng/g). Furthermore, PAHs were also found in perivitellin fluid (11.5 ± 5.0 ng/ml). Naphthalene and acenaphthene were the congeners present at highest concentrations in each analysed egg component suggesting higher bioaccumulation rates. Embryos with high concentrations of PAHs also showed a significant increase in mRNA expression for each of the analysed homeobox genes. In particular, we observed a 15-fold increase in the ARX expression levels. Additionally, the statistically significant variation in homeobox gene expression patterns was accompanied by a concomitant increase in mRNA levels of both aryl hydrocarbon receptor (AhR) and estrogen receptor (ER). These findings suggest that bioaccumulation of PAHs may modulate developmental processes of cuttlefish embryos by targeting homeobox gene-mediated transcriptional outcomes. Mechanisms underlying the upregulation of homeobox genes could be related to the ability of PAHs to directly activate AhR- or ER-related signaling pathways.
Collapse
Affiliation(s)
- Paolo Cocci
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III Da Varano, I-62032, Camerino, MC, Italy
| | - Gilberto Mosconi
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III Da Varano, I-62032, Camerino, MC, Italy
| | - Francesco Alessandro Palermo
- School of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III Da Varano, I-62032, Camerino, MC, Italy.
| |
Collapse
|
2
|
Larigot L, Bui LC, de Bouvier M, Pierre O, Pinon G, Fiocca J, Ozeir M, Tourette C, Ottolenghi C, Imbeaud S, Pontoizeau C, Blaise BJ, Chevallier A, Tomkiewicz C, Legrand B, Elena-Herrmann B, Néri C, Brinkmann V, Nioche P, Barouki R, Ventura N, Dairou J, Coumoul X. Identification of Modulators of the C. elegans Aryl Hydrocarbon Receptor and Characterization of Transcriptomic and Metabolic AhR-1 Profiles. Antioxidants (Basel) 2022; 11:antiox11051030. [PMID: 35624894 PMCID: PMC9137885 DOI: 10.3390/antiox11051030] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2022] [Revised: 05/06/2022] [Accepted: 05/18/2022] [Indexed: 02/02/2023] Open
Abstract
The Aryl hydrocarbon Receptor (AhR) is a xenobiotic sensor in vertebrates, regulating the metabolism of its own ligands. However, no ligand has been identified to date for any AhR in invertebrates. In C. elegans, the AhR ortholog, AHR-1, displays physiological functions. Therefore, we compared the transcriptomic and metabolic profiles of worms expressing AHR-1 or not and investigated the putative panel of chemical AHR-1 modulators. The metabolomic profiling indicated a role for AHR-1 in amino acids, carbohydrates, and fatty acids metabolism. The transcriptional profiling in neurons expressing AHR-1, identified 95 down-regulated genes and 76 up-regulated genes associated with neuronal and metabolic functions in the nervous system. A gene reporter system allowed us to identify several AHR-1 modulators including bacterial, dietary, or environmental compounds. These results shed new light on the biological functions of AHR-1 in C. elegans and perspectives on the evolution of the AhR functions across species.
Collapse
Affiliation(s)
- Lucie Larigot
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
- CNRS UMR 8601, Metabolism, Pharmacochemistry and Neurochemistry, Université Paris Cité, 75006 Paris, France
| | - Linh-Chi Bui
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
- Unité de biologie fonctionnelle et adaptative, UMR 8251, CNRS, Université Paris Cité, 75013 Paris, France
| | - Marine de Bouvier
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
| | - Ophélie Pierre
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
- Laboratoire Interactions Epithéliums-Neurones (LIEN), Université de Brest, EA4685, 29200 Brest, France
| | - Grégory Pinon
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
- Structural and Molecular Analysis Platform, Biomedtech Facilities, Université Paris Cité, 75006 Paris, France
| | - Justine Fiocca
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
- Structural and Molecular Analysis Platform, Biomedtech Facilities, Université Paris Cité, 75006 Paris, France
| | - Mohammad Ozeir
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
- Structural and Molecular Analysis Platform, Biomedtech Facilities, Université Paris Cité, 75006 Paris, France
| | - Cendrine Tourette
- Centre Paul Broca, INSERM U894 Neuronal Cell Biology & Pathology & EA Université Paris Cité, 75014 Paris, France;
| | - Chris Ottolenghi
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
- AP-HP, Hôpital Necker-Enfants Malades, Service de Biochimie Métabolique, 75015 Paris, France;
| | - Sandrine Imbeaud
- Gif/Orsay DNA MicroArray Platform, 91190 Gif sur Yvette, France;
| | - Clément Pontoizeau
- AP-HP, Hôpital Necker-Enfants Malades, Service de Biochimie Métabolique, 75015 Paris, France;
- Centre de Résonance Magnétique Nucléaire à Très Hauts Champs, Univ. Lyon, CNRS, UCBL, ENS Lyon, 69100 Villeurbanne, France; (B.J.B.); (B.E.-H.)
| | - Benjamin J. Blaise
- Centre de Résonance Magnétique Nucléaire à Très Hauts Champs, Univ. Lyon, CNRS, UCBL, ENS Lyon, 69100 Villeurbanne, France; (B.J.B.); (B.E.-H.)
| | - Aline Chevallier
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
| | - Céline Tomkiewicz
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
| | - Béatrice Legrand
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
| | - Bénédicte Elena-Herrmann
- Centre de Résonance Magnétique Nucléaire à Très Hauts Champs, Univ. Lyon, CNRS, UCBL, ENS Lyon, 69100 Villeurbanne, France; (B.J.B.); (B.E.-H.)
- Institute for Advanced Biosciences, Univ. Grenoble Alpes, CNRS, INSERM, 38000 Grenoble, France
| | - Christian Néri
- CNRS UMR 8256, Inserm ERL U1164, Sorbonne Université, 75005 Paris, France;
| | - Vanessa Brinkmann
- Institute of Clinical Chemistry and Laboratory Diagnostic, Medical Faculty, Heinrich Heine University, Düsseldorf, Moorenstr 5, 40225 Düsseldorf, Germany; (V.B.); (N.V.)
- Leibniz Institute for Environmental Medicine (IUF), Auf’m Hennekamp 50, 40225 Düsseldorf, Germany
| | - Pierre Nioche
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
- Structural and Molecular Analysis Platform, Biomedtech Facilities, Université Paris Cité, 75006 Paris, France
| | - Robert Barouki
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
- Assistance Publique-Hôpitaux de Paris, Hôpital Necker, 75015 Paris, France
| | - Natascia Ventura
- Institute of Clinical Chemistry and Laboratory Diagnostic, Medical Faculty, Heinrich Heine University, Düsseldorf, Moorenstr 5, 40225 Düsseldorf, Germany; (V.B.); (N.V.)
- Leibniz Institute for Environmental Medicine (IUF), Auf’m Hennekamp 50, 40225 Düsseldorf, Germany
| | - Julien Dairou
- CNRS UMR 8601, Metabolism, Pharmacochemistry and Neurochemistry, Université Paris Cité, 75006 Paris, France
- Correspondence: (J.D.); (X.C.); Tel.: +33-1-42-86-91-21 (J.D.); +33-1-42-86-33-59 (X.C.)
| | - Xavier Coumoul
- INSERM UMR-S1124, T3S, Toxicologie Environnementale, Cibles Thérapeutiques, Signalisation Cellulaire et Biomarqueurs, Université Paris Cité, 75006 Paris, France; (L.L.); (L.-C.B.); (M.d.B.); (O.P.); (G.P.); (J.F.); (M.O.); (C.O.); (A.C.); (C.T.); (B.L.); (P.N.); (R.B.)
- Correspondence: (J.D.); (X.C.); Tel.: +33-1-42-86-91-21 (J.D.); +33-1-42-86-33-59 (X.C.)
| |
Collapse
|
3
|
Hartman JH, Widmayer SJ, Bergemann CM, King DE, Morton KS, Romersi RF, Jameson LE, Leung MCK, Andersen EC, Taubert S, Meyer JN. Xenobiotic metabolism and transport in Caenorhabditis elegans. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH. PART B, CRITICAL REVIEWS 2021; 24:51-94. [PMID: 33616007 PMCID: PMC7958427 DOI: 10.1080/10937404.2021.1884921] [Citation(s) in RCA: 53] [Impact Index Per Article: 17.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
Caenorhabditis elegans has emerged as a major model in biomedical and environmental toxicology. Numerous papers on toxicology and pharmacology in C. elegans have been published, and this species has now been adopted by investigators in academic toxicology, pharmacology, and drug discovery labs. C. elegans has also attracted the interest of governmental regulatory agencies charged with evaluating the safety of chemicals. However, a major, fundamental aspect of toxicological science remains underdeveloped in C. elegans: xenobiotic metabolism and transport processes that are critical to understanding toxicokinetics and toxicodynamics, and extrapolation to other species. The aim of this review was to initially briefly describe the history and trajectory of the use of C. elegans in toxicological and pharmacological studies. Subsequently, physical barriers to chemical uptake and the role of the worm microbiome in xenobiotic transformation were described. Then a review of what is and is not known regarding the classic Phase I, Phase II, and Phase III processes was performed. In addition, the following were discussed (1) regulation of xenobiotic metabolism; (2) review of published toxicokinetics for specific chemicals; and (3) genetic diversity of these processes in C. elegans. Finally, worm xenobiotic transport and metabolism was placed in an evolutionary context; key areas for future research highlighted; and implications for extrapolating C. elegans toxicity results to other species discussed.
Collapse
Affiliation(s)
- Jessica H Hartman
- Nicholas School of the Environment, Duke University, Durham, North Carolina
| | - Samuel J Widmayer
- Department of Molecular Biosciences, Northwestern University, Evanston, Illinois, United States
| | | | - Dillon E King
- Nicholas School of the Environment, Duke University, Durham, North Carolina
| | - Katherine S Morton
- Nicholas School of the Environment, Duke University, Durham, North Carolina
| | - Riccardo F Romersi
- Nicholas School of the Environment, Duke University, Durham, North Carolina
| | - Laura E Jameson
- School of Mathematical and Natural Sciences, Arizona State University - West Campus, Glendale, Arizona, United States
| | - Maxwell C K Leung
- School of Mathematical and Natural Sciences, Arizona State University - West Campus, Glendale, Arizona, United States
| | - Erik C Andersen
- Department of Molecular Biosciences, Northwestern University, Evanston, Illinois, United States
| | - Stefan Taubert
- Dept. Of Medical Genetics, Centre for Molecular Medicine and Therapeutics, BC Children's Hospital Research Institute, the University of British Colombia, Vancouver, BC, Canada
| | - Joel N Meyer
- Nicholas School of the Environment, Duke University, Durham, North Carolina
| |
Collapse
|
4
|
Hahn ME, Karchner SI, Merson RR. Diversity as Opportunity: Insights from 600 Million Years of AHR Evolution. CURRENT OPINION IN TOXICOLOGY 2017; 2:58-71. [PMID: 28286876 DOI: 10.1016/j.cotox.2017.02.003] [Citation(s) in RCA: 85] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
The aryl hydrocarbon receptor (AHR) was for many years of interest only to pharmacologists and toxicologists. However, this protein has fundamental roles in biology that are being revealed through studies in diverse animal species. The AHR is an ancient protein. AHR homologs exist in most major groups of modern bilaterian animals, including deuterostomes (chordates, hemichordates, echinoderms) and the two major clades of protostome invertebrates [ecdysozoans (e.g. arthropods and nematodes) and lophotrochozoans (e.g. molluscs and annelids)]. AHR homologs also have been identified in cnidarians such as the sea anemone Nematostella and in the genome of Trichoplax, a placozoan. Bilaterians, cnidarians, and placozoans form the clade Eumetazoa, whose last common ancestor lived approximately 600 million years ago (MYA). The presence of AHR homologs in modern representatives of all these groups indicates that the original eumetazoan animal possessed an AHR homolog. Studies in invertebrates and vertebrates reveal parallel functions of AHR in the development and function of sensory neural systems, suggesting that these may be ancestral roles. Vertebrate animals are characterized by the expansion and diversification of AHRs, via gene and genome duplications, from the ancestral protoAHR into at least five classes of AHR-like proteins: AHR, AHR1, AHR2, AHR3, and AHRR. The evolution of multiple AHRs in vertebrates coincided with the acquisition of high-affinity binding of halogenated and polynuclear aromatic hydrocarbons and the emergence of adaptive functions involving regulation of xenobiotic-metabolizing enzymes and roles in adaptive immunity. The existence of multiple AHRs may have facilitated subfunction partitioning and specialization of specific AHR types in some taxa. Additional research in diverse model and non-model species will continue to enrich our understanding of AHR and its pleiotropic roles in biology and toxicology.
Collapse
Affiliation(s)
- Mark E Hahn
- Biology Department, Woods Hole Oceanographic Institution, MS-32, Woods Hole, MA 02543, USA
| | - Sibel I Karchner
- Biology Department, Woods Hole Oceanographic Institution, MS-32, Woods Hole, MA 02543, USA
| | - Rebeka R Merson
- Biology Department, Rhode Island College, 600 Mt. Pleasant Avenue, 251 Fogarty Life Sciences, Providence, RI 02908
| |
Collapse
|